Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Tauopathies: new perspectives and challenges
Y Zhang, KM Wu, L Yang, Q Dong, JT Yu - Molecular Neurodegeneration, 2022 - Springer
Background Tauopathies are a class of neurodegenerative disorders characterized by
neuronal and/or glial tau-positive inclusions. Main body Clinically, tauopathies can present …
neuronal and/or glial tau-positive inclusions. Main body Clinically, tauopathies can present …
Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies
Tauopathies are classified according to whether tau deposits predominantly contain tau
isoforms with three or four repeats of the microtubule-binding domain. Those in which four …
isoforms with three or four repeats of the microtubule-binding domain. Those in which four …
Neuropathology and emerging biomarkers in corticobasal syndrome
Corticobasal syndrome (CBS) is a clinical syndrome characterised by progressive
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
Objective To assess the diagnostic and prognostic value of serum neurofilament light (NfL)
and serum phospho-Tau181 (p-Tau181) in a large cohort of patients with frontotemporal …
and serum phospho-Tau181 (p-Tau181) in a large cohort of patients with frontotemporal …
Validation of α‐synuclein in L1CAM‐immunocaptured exosomes as a biomarker for the stratification of parkinsonian syndromes
Background Parkinson's disease is characterized by intraneuronal α‐synuclein aggregation.
Currently there is no α‐synuclein‐based blood test in clinical practice. Objectives Our aim …
Currently there is no α‐synuclein‐based blood test in clinical practice. Objectives Our aim …
Lewy body disease or diseases with Lewy bodies?
The current nosological concept of α-synucleinopathies characterized by the presence of
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …
Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD) …
Cortical [18F]PI‐2620 Binding Differentiates Corticobasal Syndrome Subtypes
Background Corticobasal syndrome is associated with cerebral protein aggregates
composed of 4‐repeat (~ 50% of cases) or mixed 3‐repeat/4‐repeat tau isoforms (~ 25% of …
composed of 4‐repeat (~ 50% of cases) or mixed 3‐repeat/4‐repeat tau isoforms (~ 25% of …
Fluid biomarkers in frontotemporal dementia: past, present and future
IJ Swift, A Sogorb-Esteve, C Heller… - Journal of Neurology …, 2021 - jnnp.bmj.com
The frontotemporal dementia (FTD) spectrum of neurodegenerative disorders includes a
heterogeneous group of conditions. However, following on from a series of important …
heterogeneous group of conditions. However, following on from a series of important …
Evaluating the effect of Alzheimer's disease‐related biomarker change in corticobasal syndrome and progressive supranuclear palsy
Objectives To evaluate the effect of Alzheimer's disease (AD)‐related biomarker change on
clinical features, brain atrophy and functional connectivity of patients with corticobasal …
clinical features, brain atrophy and functional connectivity of patients with corticobasal …
Synaptic Loss in Primary Tauopathies Revealed by [11C]UCB‐J Positron Emission Tomography
Background Synaptic loss is a prominent and early feature of many neurodegenerative
diseases. Objectives We tested the hypothesis that synaptic density is reduced in the …
diseases. Objectives We tested the hypothesis that synaptic density is reduced in the …